As of 2024-12-14, the Intrinsic Value of Citius Pharmaceuticals Inc (CTXR) is
-26.48 USD. This CTXR valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.79 USD, the upside of Citius Pharmaceuticals Inc is
-1,049.17%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-26.48 USD
Intrinsic Value
CTXR Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-26.48 - -26.48 |
-26.48 |
-1,049.17% |
| P/E |
(118.53) - (132.62) |
(127.91) |
-4684.5% |
| DDM - Stable |
(34.92) - (96.86) |
(65.89) |
-2461.6% |
| DDM - Multi |
(23.32) - (51.19) |
(32.14) |
-1251.8% |
CTXR Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
20.17 |
| Beta |
0.46 |
| Outstanding shares (mil) |
7.23 |
| Enterprise Value (mil) |
2.26 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.77% |
| Cost of Debt |
5.00% |
| WACC |
7.72% |